Cyxone
0,09 SEK -0,88%Vær den første som følger denne virksomhed
Cyxone is a biotechnology company. The company's specialist expertise is found in the development of pharmaceuticals with a focus on plant protein as a base. The pharmaceutical is intended to be used mainly in the treatment of immune-related diseases, and the products are based on cyclotide technology. The purpose is that the pharmaceutical will be used in the treatment of multiple sclerosis and rheumatoid arthritis. Cyxone's head office is located in Malmö.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
CYXO
Daglig lav / høj pris
0,085 / 0,091
SEK
Markedsværdi
19,48 mio. SEK
Aktieomsætning
74,05 t SEK
Volumen
831 t
Seneste videoer
Finanskalender
Delårsrapport
14.05.2024
Generalforsamling
30.05.2024
Delårsrapport
29.08.2024
Delårsrapport
07.11.2024
Årsrapport
25.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Avanza Pension | 5,0 % | 5,0 % |
Nordnet Pensionsförsäkring | 4,1 % | 4,1 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
BioStock: Cyxone comments on the clinical collaboration in the UK
Cyxone enters important research collaboration
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools